No Data
Denali Therapeutics Insider Sold Shares Worth $549,928, According to a Recent SEC Filing
Denali Therapeutics (NASDAQ:DNLI) Investors Are Sitting on a Loss of 55% If They Invested Three Years Ago
H.C. Wainwright Maintains Denali Therapeutics(DNLI.US) With Buy Rating, Maintains Target Price $90
Denali Therapeutics' OTV Platform: A Revolutionary Leap in Neurodegenerative Disease Treatment
Express News | Denali Therapeutics Announces Publication in Science Translational Medicine Demonstrating the Potential of the Oligonucleotide Transport Vehicle Platform to Achieve Broad Biodistribution of Antisense Oligonucleotides in the CNS and Muscle Following Intrav
Denali Therapeutics Announces Publication In 'Science Translational Medicine' Demonstrating The Potential Of The OTV Platform To Achieve Broad Biodistribution Of Antisense Oligonucleotides In The CNS And Skeletal And Cardiac Muscle Following IV...